Literature DB >> 22348847

[Changes in cognitive function in patients with diabetes mellitus].

Barbara Szémán1, Géza Nagy, Tímea Varga, Anna Veres-Székely, Mária Sasvári, Dávid Fitala, Adrienn Szollosi, Rózsa Katonai, Eszter Kotyuk, Anikó Somogyi.   

Abstract

Patients with diabetes are approximately 1.5 times more likely to experience cognitive decline than individuals without diabetes mellitus. Most of the data suggest that patients with diabetes have reduced performance in numerous domains of cognitive function. In patients with type 1 diabetes, specific and global deficits involving speed of psychomotor efficiency, information processing, mental flexibility, attention, and visual perception seem to be present, while in patients with type 2 diabetes an increase in memory deficits, a reduction in psychomotor speed, and reduced frontal lobe (executive) functions have been found. The complex pathophysiology of changes in the central nervous system in diabetes has not yet been fully elucidated. It is important to consider the patient's age at the onset of diabetes, the glycemic control status, and the presence of diabetic complications. Neurological consequences of diabetes appear parallel to those observed in the aging brain. Neuroimaging studies highlight several structural cerebral changes, cortical and subcortical atrophy, beside increased leukoaraiosis that occurs in association with diabetes. There is supporting evidence from many hypotheses to explain the pathophysiology of cognitive decline associated with diabetes. The main hypotheses pointing to the potential, implied mechanisms involve hyperglycemia, hypoglycemia, microvascular disease, insulin resistance, hyperinsulinism, hyperphosphorylation of tau protein, and amyloid-β deposition.

Entities:  

Mesh:

Year:  2012        PMID: 22348847     DOI: 10.1556/OH.2012.29319

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  8 in total

1.  Impairment of the glymphatic system after diabetes.

Authors:  Quan Jiang; Li Zhang; Guangliang Ding; Esmaeil Davoodi-Bojd; Qingjiang Li; Lian Li; Neema Sadry; Maiken Nedergaard; Michael Chopp; Zhenggang Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 2.  Overlapped metabolic and therapeutic links between Alzheimer and diabetes.

Authors:  Waqar Ahmad
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

3.  Low plasma BDNF is not a biomarker for cognitive dysfunction in elderly T2DM patients.

Authors:  Qing-Guo Ren; Jing-Hao Chang; Wan-Jun Lu; Wei-Gang Gong; Hong Zhou
Journal:  Neurol Sci       Date:  2017-07-05       Impact factor: 3.307

4.  Low BDNF is associated with cognitive deficits in patients with type 2 diabetes.

Authors:  Yan Feng Zhen; Jia Zhang; Xing Yu Liu; Hui Fang; Luo Bing Tian; Dong Hao Zhou; Thomas R Kosten; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2012-12-22       Impact factor: 4.530

5.  Does social support affect development of cognitive dysfunction in individuals with diabetes mellitus?

Authors:  Feride T Yilmaz; Selma Sabancıogullari; Kadriye Aldemir; Azime K Kumsar
Journal:  Saudi Med J       Date:  2015-12       Impact factor: 1.484

6.  Association of plasma ghrelin levels and ghrelin rs4684677 polymorphism with mild cognitive impairment in type 2 diabetic patients.

Authors:  Rong Huang; Jing Han; Sai Tian; Rongrong Cai; Jie Sun; Yanjue Shen; Shaohua Wang
Journal:  Oncotarget       Date:  2017-02-28

7.  Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort.

Authors:  Wei Li; Shannon L Risacher; Edgar Huang; Andrew J Saykin
Journal:  Neurology       Date:  2016-07-06       Impact factor: 9.910

8.  A systematic review and meta-analysis of association between brain-derived neurotrophic factor and type 2 diabetes and glycemic profile.

Authors:  Milad Davarpanah; Nafiseh Shokri-Mashhadi; Rahele Ziaei; Parvane Saneei
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.